- Home
- NMRA vs PSF Comparison
NMRA vs PSF Comparison
Compare NMRA & PSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- PSF
- Stock Information
- Founded
- NMRA 2019
- PSF 2010
- Country
- NMRA United States
- PSF United States
- Employees
- NMRA N/A
- PSF N/A
- Industry
- NMRA
- PSF Investment Managers
- Sector
- NMRA
- PSF Finance
- Exchange
- NMRA Nasdaq
- PSF Nasdaq
- Market Cap
- NMRA 234.5M
- PSF 236.8M
- IPO Year
- NMRA 2023
- PSF N/A
- Fundamental
- Price
- NMRA $2.08
- PSF $20.54
- Analyst Decision
- NMRA Buy
- PSF
- Analyst Count
- NMRA 8
- PSF 0
- Target Price
- NMRA $7.14
- PSF N/A
- AVG Volume (30 Days)
- NMRA 2.2M
- PSF 25.0K
- Earning Date
- NMRA 08-06-2025
- PSF 01-01-0001
- Dividend Yield
- NMRA N/A
- PSF 7.69%
- EPS Growth
- NMRA N/A
- PSF N/A
- EPS
- NMRA N/A
- PSF N/A
- Revenue
- NMRA N/A
- PSF N/A
- Revenue This Year
- NMRA N/A
- PSF N/A
- Revenue Next Year
- NMRA N/A
- PSF N/A
- P/E Ratio
- NMRA N/A
- PSF N/A
- Revenue Growth
- NMRA N/A
- PSF N/A
- 52 Week Low
- NMRA $0.61
- PSF $16.00
- 52 Week High
- NMRA $17.19
- PSF $20.19
- Technical
- Relative Strength Index (RSI)
- NMRA 70.06
- PSF 69.49
- Support Level
- NMRA $1.70
- PSF $20.42
- Resistance Level
- NMRA $2.85
- PSF $20.17
- Average True Range (ATR)
- NMRA 0.32
- PSF 0.12
- MACD
- NMRA 0.05
- PSF 0.01
- Stochastic Oscillator
- NMRA 58.08
- PSF 97.20
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About PSF Cohen & Steers Select Preferred and Income Fund Inc.
Cohen & Steers Select Preferred and Income Fund Inc is a diversified, closed-end investment company. The Fund's primary investment objective is high current income with capital appreciation as its secondary objective. The Fund invests at least of its Managed Assets in preferred and other income securities issued by U.S. and non-U.S. companies.